Ticker
ORMPCompany Name
ORAMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 99.03M | 26.81 | $ 3.69M |
3/31/2025 | $ 131.48M | 23.94 | $ 5.49M |
12/31/2024 | $ 143.22M | 25.19 | $ 5.68M |
9/30/2024 | $ 142.77M | 27.08 | $ 5.27M |
6/30/2024 | $ 153.27M | 41.06 | $ 3.73M |
3/31/2024 | $ 177.09M | 5.28 | $ 33.56M |
12/31/2023 | $ 162.58M | 3.06 | $ 53.21M |
9/30/2023 | $ 175.71M | 2.25 | $ 78.17M |
6/30/2023 | $ 150.97M | 141.49 | $ 1.07M |
3/31/2023 | $ 155.16M | 31.21 | $ 4.97M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for ORAMED PHARMACEUTICALS INC is calculated as follows: AssetsC [ $ 40.51M ] / LiabilitesC [ $ 4.54M ]
(=) Current Ratio [ 8.93 ]
Minimum
Sep 30, 2023
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |